STAT 3 inhibitors (rapamicin, mTOR inhibitors such as sirolimus, or STAT3 inhibitor XVIII) were shown to be effective in PV in animal studies by increasing Dsg3 expression [110,111]. This evidence concerns the gene DSG3 and acquired polycythemia vera.